Search Results 241-250 of 17317 for Proto-oncogene

  1. Mayo Clinic researchers discover 'traffic controller' protein that protects DNA, and may help kill cancer cells

    Mayo Clinic researchers found a protein that plays a surprising yet critical role in protecting and repairing DNA.

  2. A Study of Application of Clonal Analysis to Study Flow Sorted Clinical Samples from Patients with Advanced Solid Tumors - Mayo Clinic

    This study is being done so researchers can study the genetics of your tumor to better understand how the tumor grows and spreads and collect a blood sample to ...

  3. Polycystic kidney disease - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Mayo Clinic's Phospholipid Signaling in Embryonic Development and Human Diseases Lab led by Kun Ling, Ph.D., studies polycystic kidney disease.

  4. Q702 For The Treatment Of Patients With Hematologic Malignancies - Mayo Clinic

    ... oncogene homolog B (BRAF) or Mitogen-activated protein kinase kinase (MAP2K) oncogenes who have progressed after first line of therapy. Note: Relapsed is ...

  5. Overview - Tumor Microenvironment Laboratory - Mayo Clinic Research

    Dr. Radisky's Tumor Microenvironment Lab at Mayo Clinic studies the earliest stages of cancer development to find new methods to treat breast cancer and ...

  6. Medical Research & Education - Mayo Clinic News Network

    Not the end of the road: Delivering the diagnosis of sex-chromosome trisomy. Mayo Clinic Staff. March 19, 2019. Mayo Clinic Radio: Fibromyalgia / sensitized ...

  7. ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D - Mayo Clinic

    ... oncogene amplification, expression level of PTEN and presence or absence of the p95HER2 receptor. On August 18, 2011, the ALTTO Independent Data Monitoring ...

  8. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  9. AI-driven drug discovery - Microenvironments and Applied Nanomedicine Laboratory - Mayo Clinic Research

    ... oncogenic signaling. Preclinical studies demonstrated that GIPCi significantly suppressed tumor growth, enhanced the efficacy of gemcitabine, remodeled the ...

  10. A Study Of Tumor DNA Mutations In The Peripheral Blood From Patients Who Have Cholangiocarcinoma - Mayo Clinic

    About this study. The purpose of this study is to investigate the usefulness of identifying DNA mutations in circulating tumor cells and cfDNA from the ...